These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19006608)

  • 1. Long-term proton pump inhibitor use and gastrointestinal cancer.
    Graham DY; Genta RM
    Curr Gastroenterol Rep; 2008 Dec; 10(6):543-7. PubMed ID: 19006608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.
    Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Reduction in Gastric Atrophy after
    Niikura R; Hayakawa Y; Hirata Y; Ogura K; Fujishiro M; Yamada A; Ushiku T; Konishi M; Fukayama M; Koike K
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
    Eissele R; Brunner G; Simon B; Solcia E; Arnold R
    Gastroenterology; 1997 Mar; 112(3):707-17. PubMed ID: 9041231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
    Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
    Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
    Laine L; Ahnen D; McClain C; Solcia E; Walsh JH
    Aliment Pharmacol Ther; 2000 Jun; 14(6):651-68. PubMed ID: 10848649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems associated with the clinical use of proton pump inhibitors.
    Gillen D; McColl KE
    Pharmacol Toxicol; 2001 Dec; 89(6):281-6. PubMed ID: 11903952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
    Lamberts R
    Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors.
    Gao W; Huang Y; Lu S; Li C
    Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
    Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
    Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Vonoprazan for Helicobacter pylori Eradication.
    Kiyotoki S; Nishikawa J; Sakaida I
    Intern Med; 2020 Jan; 59(2):153-161. PubMed ID: 31243237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
    Vakil N
    Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
    Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2002 Jan; 16(1):159-65. PubMed ID: 11856091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
    Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
    Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
    Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.